alluvi-retatrutide735853 - Profile

About me

Profile

Alluvi, previously BI 4744, represents a promising development in obesity treatment. This dual agonist targeting both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide

https://alluvi-research.co.uk/product/alluvi-retatrutide-40mg-rd-only/